ALSO READShilpa Medicare consolidated net profit declines 0.69% in the March 2017 quarter Shilpa Medicare standalone net profit rises 23.45% in the March 2017 quarter Shilpa Medicare gets EIR from USFDA for Raichur facilities Shilpa Medicare spurts as USFDA accepts corrective action plan Shilpa Medicare provides update on USFDA inspection of its API manufacturing facility at Raichur, Karnataka
Sales decline 0.13% to Rs 158.08 croreNet profit of Shilpa Medicare rose 15.73% to Rs 27.88 crore in the quarter ended June 2017 as against Rs 24.09 crore during the previous quarter ended June 2016.
Sales declined 0.13% to Rs 158.08 crore in the quarter ended June 2017 as against Rs 158.29 crore during the previous quarter ended June 2016. ParticularsQuarter EndedJun. 2017Jun. 2016% Var.Sales158.08158.29 0 OPM %25.0422.67 -PBDT44.3237.70 18 PBT37.2031.65 18 NP27.8824.09 16
Powered by Capital Market - Live News
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)